Journal
CANCER LETTERS
Volume 268, Issue 2, Pages 244-251Publisher
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2008.03.054
Keywords
photodynamic theraph; talaporfin sodium; tumor; morphological heterogeneity; VEGF
Categories
Funding
- Special Coordination Funds For Promoting Science and Technology
- Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
Ask authors/readers for more resources
Photodynamic therapy (PDT) involves the administration of a photosensitizer, followed by local illumination of a tumor with a laser (of the appropriate wavelength) to activate a specific drug. However. the cells in a tumor tissue are heterogeneous. in terms of their morphologies and differentiation statuses, even if the tumor consists of progeny developed from a single neoplastic cell. It is not known how tumor cell heterogeneity affects their sensitivity to PDT. Here, we demonstrate that a single tumor cell has the potential to produce a progeny that is heterogeneous in terms of morphology, VEGF secretion, and PDT sensitivity, irrespective of intracellular photosensitizer amount. Understanding tumor cell heterogeneity for clinical applications of PDT will help in the design of new interventions and potentially improve long-term survival of PDT treated patients. (c) 2008 Elsevier Ireland Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available